AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32220944 — intervention group
Group type: EXPERIMENTAL
Intervention: Early specialised palliative care (SPC) interventions
Number of subjects: 145
Study 32220944 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain interventions
Number of subjects: 145
Study 32220944 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired physical function interventions
Number of subjects: 145
Study 32220944 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological interventions
Number of subjects: 145
Study 32220944 — intervention group
Group type: EXPERIMENTAL
Intervention: No documented interventions
Number of subjects: 145
Study 32460565 — intervention group
Group type: EXPERIMENTAL
Intervention: Calendula ointment
Number of subjects: 100
Study 32460565 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 100
Study 32698121 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher protein diet (2.50 g·kg‐1·day‐1)
Number of subjects: 18
Study 32698121 — intervention group
Group type: COMPARATOR
Intervention: Moderate protein diet (1.25 g·kg‐1·day‐1)
Number of subjects: 18
Study 34175001 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted self-help intervention (eTARGET group)
Number of subjects: 2896
Study 34175001 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic smoking cessation self-help booklets (GENERIC group)
Number of subjects: 2896
Study 34175001 — intervention group
Group type: COMPARATOR
Intervention: Assessment only (ASSESS group)
Number of subjects: 2896
Study 32295645 — intervention group
Group type: EXPERIMENTAL
Intervention: Motion-control shoes
Number of subjects: 92
Study 32295645 — intervention group
Group type: COMPARATOR
Intervention: Neutral shoes
Number of subjects: 92
Study 36110573 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive nursing (OG)
Number of subjects: 180
Study 36110573 — intervention group
Group type: COMPARATOR
Intervention: Conventional nursing (CG)
Number of subjects: 180
Study 33075806 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg) added to verinurad (9 mg) and febuxostat (80 mg)
Number of subjects: 36
Study 33075806 — intervention group
Group type: COMPARATOR
Intervention: Placebo added to verinurad (9 mg) and febuxostat (80 mg)
Number of subjects: 36
Study 33075806 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg)
Number of subjects: 36
Study 32063089 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplement (LNS) provided to women during gestation and the first 6 months postpartum and to their infants from age 6 to 18 months.
Number of subjects: 364
Study 32063089 — intervention group
Group type: COMPARATOR
Intervention: Iron and folic acid (IFA) during gestation with no infant supplementation.
Number of subjects: 364
Study 32063089 — intervention group
Group type: COMPARATOR
Intervention: Multiple micronutrients during gestation and the first 6 months postpartum, with no infant supplementation.
Number of subjects: 364
Study 33527249 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline ultrasound (SIS)
Number of subjects: 100
Study 33527249 — intervention group
Group type: EXPERIMENTAL
Intervention: Office hysteroscopy (HSC)
Number of subjects: 100
Study 33527249 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SIS and HSC
Number of subjects: 100
Study 35189374 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally-tailored infographic
Number of subjects: 1100
Study 35189374 — intervention group
Group type: COMPARATOR
Intervention: Traditional standard infographic
Number of subjects: 1100
Study 35189374 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally-tailored comic book
Number of subjects: 1100
Study 35300944 — intervention group
Group type: EXPERIMENTAL
Intervention: SCF-N-treated needles
Number of subjects: 0
Study 35300944 — intervention group
Group type: COMPARATOR
Intervention: Stainless steel needles
Number of subjects: 0
Study 32246762 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (400 mg pessary) once daily until 37 weeks
Number of subjects: 0
Study 32246762 — intervention group
Group type: COMPARATOR
Intervention: No progesterone
Number of subjects: 0
Study 35953433 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasobiliary catheter insertion during ERCP (NB group)
Number of subjects: 110
Study 35953433 — intervention group
Group type: COMPARATOR
Intervention: Control group (only CBD clearance)
Number of subjects: 110
Study 33599345 — intervention group
Group type: EXPERIMENTAL
Intervention: Crocin (15 mg)
Number of subjects: 50
Study 33599345 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine (20 mg)
Number of subjects: 50
Study 33148013 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban 60 mg (30 mg dose-reduced)
Number of subjects: 14024
Study 33148013 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 14024
Study 35661856 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic symptom monitoring with PRO surveys (n=593)
Number of subjects: 1191
Study 35661856 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=598)
Number of subjects: 1191
Study 35781768 — intervention group
Group type: EXPERIMENTAL
Intervention: Population-screening (PS)
Number of subjects: 1034
Study 35781768 — intervention group
Group type: COMPARATOR
Intervention: Family history (FH)
Number of subjects: 1034
Study 35781768 — intervention group
Group type: EXPERIMENTAL
Intervention: Population-screening (PS) and Family history (FH)
Number of subjects: 1034
Study 35781768 — intervention group
Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 1034
Study 33992536 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous autologous bone marrow-derived mesenchymal stromal cells (BMMSCs) at a dosage of 2 million cells per kilogram of body weight
Number of subjects: 17
Study 33992536 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care (control group)
Number of subjects: 17
Study 32290880 — intervention group
Group type: EXPERIMENTAL
Intervention: Fundraising Incentive (FI)
Number of subjects: 81
Study 32290880 — intervention group
Group type: EXPERIMENTAL
Intervention: Fundraising-Healthy Eating Incentive (F-HEI)
Number of subjects: 81
Study 32290880 — intervention group
Group type: COMPARATOR
Intervention: Comparison 1
Number of subjects: 81
Study 34433601 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary group programme (Energetic) consisting of a 4 months intervention with weekly meetings covering four modules: aerobic exercise training, education about aerobic exercise, self-management training, and implementation and relapse prevention.
Number of subjects: 29
Study 34433601 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative data collection through individual and focus group interviews.
Number of subjects: 29
Study 34433601 — intervention group
Group type: EXPERIMENTAL
Intervention: Suggestions for programme improvement include a combination of face to face and e-health, enhancement of therapists' skills, and inclusion of more booster sessions.
Number of subjects: 29
Study 34319941 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous bilateral resistance training (BIL)
Number of subjects: 24
Study 34319941 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating unilateral resistance training (AUL)
Number of subjects: 24
Study 34319941 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 24
Study 33744205 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpositional gap arthroplasty followed by reconstruction of the ramus-condyle unit using vertical ramus osteotomy
Number of subjects: 16
Study 33744205 — intervention group
Group type: COMPARATOR
Intervention: Interpositional gap arthroplasty
Number of subjects: 16
Study 33110649 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccine
Number of subjects: 201
Study 33110649 — intervention group
Group type: COMPARATOR
Intervention: Topical salicylic acid (SA)
Number of subjects: 201
Study 36029051 — intervention group
Group type: EXPERIMENTAL
Intervention: 10000 IU of hCG plus 450 IU of FSH
Number of subjects: 117
Study 36029051 — intervention group
Group type: COMPARATOR
Intervention: 10000 IU of hCG alone
Number of subjects: 117
Study 33609965 — intervention group
Group type: EXPERIMENTAL
Intervention: Letters of invitation for cervical cancer screening
Number of subjects: 0
Study 33609965 — intervention group
Group type: COMPARATOR
Intervention: Different ways of framing messages
Number of subjects: 0
Study 36347387 — intervention group
Group type: EXPERIMENTAL
Intervention: MSC therapy (infused at weeks 6 and 7 after transplantation, tacrolimus withdrawn at week 8)
Number of subjects: 54
Study 36347387 — intervention group
Group type: EXPERIMENTAL
Intervention: MSC therapy
Number of subjects: 54
Study 36347387 — intervention group
Group type: COMPARATOR
Intervention: Standard tacrolimus dose (control group)
Number of subjects: 54
Study 34433000 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Speech Intervention (HISI)
Number of subjects: 12
Study 34433000 — intervention group
Group type: COMPARATOR
Intervention: Low-Intensity Speech Intervention (LISI)
Number of subjects: 12
Study 32187609 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod (FIN)
Number of subjects: 388
Study 32187609 — intervention group
Group type: COMPARATOR
Intervention: Natalizumab (NTZ)
Number of subjects: 388
Study 36175473 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT)
Number of subjects: 25
Study 36175473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 33161000 — intervention group
Group type: EXPERIMENTAL
Intervention: Endodontic microsurgery (EMS) treated teeth
Number of subjects: 14
Study 33161000 — intervention group
Group type: COMPARATOR
Intervention: Control teeth
Number of subjects: 14
Study 35289144 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-mSv CT
Number of subjects: 3074
Study 35289144 — intervention group
Group type: COMPARATOR
Intervention: Conventional-dose CT
Number of subjects: 3074
Study 34962110 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV-VG
Number of subjects: 80
Study 34962110 — intervention group
Group type: COMPARATOR
Intervention: VCV
Number of subjects: 80
Study 34582545 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Carb diet (20% carbohydrate, 21% saturated fat)
Number of subjects: 164
Study 34582545 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Carb diet (40% carbohydrate, 14% saturated fat)
Number of subjects: 164
Study 34582545 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Carb diet (60% carbohydrate, 7% saturated fat)
Number of subjects: 164
Study 32354945 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab monotherapy
Number of subjects: 32
Study 34587873 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise program (8 weeks, home-based)
Number of subjects: 34
Study 34587873 — intervention group
Group type: COMPARATOR
Intervention: Routine activities (control group)
Number of subjects: 34
Study 32820132 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined strength and power training (twice a week for 8 weeks)
Number of subjects: 37
Study 32820132 — intervention group
Group type: COMPARATOR
Intervention: Soccer training alone (control group)
Number of subjects: 37
Study 35831410 — intervention group
Group type: EXPERIMENTAL
Intervention: Gold weight fixed 2 mm above the eyelash line (GLE group)
Number of subjects: 94
Study 35831410 — intervention group
Group type: EXPERIMENTAL
Intervention: Gold weight fixed at the border of the tarsus and the levator aponeurosis (GUE group)
Number of subjects: 94
Study 35831410 — intervention group
Group type: EXPERIMENTAL
Intervention: Platinum chain fixed at the border of the tarsus and the levator aponeurosis (PUE group)
Number of subjects: 94
Study 32657253 — intervention group
Group type: EXPERIMENTAL
Intervention: Diesel exhaust (DE) exposure
Number of subjects: 16
Study 32207134 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia (GA)
Number of subjects: 105
Study 32207134 — intervention group
Group type: COMPARATOR
Intervention: Spinal anesthesia (SA)
Number of subjects: 105
Study 32207134 — intervention group
Group type: COMPARATOR
Intervention: Epidural anesthesia (EA)
Number of subjects: 105
Study 35396456 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm-cycle ergometry (ACET)
Number of subjects: 35
Study 35396456 — intervention group
Group type: COMPARATOR
Intervention: Body weight supported treadmill training (BWSTT)
Number of subjects: 35
Study 33275811 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissonance-based (DB) intervention
Number of subjects: 180
Study 33275811 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control (AOC)
Number of subjects: 180
Study 33099850 — intervention group
Group type: EXPERIMENTAL
Intervention: Coolsense plus standard care
Number of subjects: 40
Study 33099850 — intervention group
Group type: EXPERIMENTAL
Intervention: Buzzy with cold plus standard care
Number of subjects: 40
Study 33099850 — intervention group
Group type: EXPERIMENTAL
Intervention: Buzzy without cold plus standard care
Number of subjects: 40
Study 33099850 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone (distraction with bubbles)
Number of subjects: 40
Study 33082214 — intervention group
Group type: EXPERIMENTAL
Intervention: FGFR1 copy-number gains (CNGs)
Number of subjects: 598
Study 33082214 — intervention group
Group type: EXPERIMENTAL
Intervention: PIK3CA mutations
Number of subjects: 598
Study 33082214 — intervention group
Group type: EXPERIMENTAL
Intervention: MYC CNGs
Number of subjects: 598
Study 33082214 — intervention group
Group type: EXPERIMENTAL
Intervention: CCND1 CNGs
Number of subjects: 598
Study 33082214 — intervention group
Group type: EXPERIMENTAL
Intervention: ERBB2 CNGs
Number of subjects: 598
Study 32078716 — intervention group
Group type: EXPERIMENTAL
Intervention: Training cohort (n=6941)
Number of subjects: 9917
Study 32078716 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine and Gray's model
Number of subjects: 9917
Study 32078716 — intervention group
Group type: EXPERIMENTAL
Intervention: Competing risk nomogram
Number of subjects: 9917
Study 32324130 — intervention group
Group type: COMPARATOR
Intervention: NAPSO 220 mg
Number of subjects: 0
Study 32324130 — intervention group
Group type: COMPARATOR
Intervention: NAPSO 440 mg
Number of subjects: 0
Study 32324130 — intervention group
Group type: COMPARATOR
Intervention: NAPSO 550 mg
Number of subjects: 0
Study 32324130 — intervention group
Group type: COMPARATOR
Intervention: NAP 500 mg
Number of subjects: 0
Study 32324130 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher doses of NAPSO
Number of subjects: 0
Study 32324130 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower doses of NAPSO (220 mg, 440 mg)
Number of subjects: 0
Study 32324130 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher strengths of NAPSO
Number of subjects: 0
Study 32324130 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatments
Number of subjects: 0
Study 34358343 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab (300 mg) every 2 weeks for 16 weeks
Number of subjects: 165
Study 34358343 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab (300 mg)
Number of subjects: 165
Study 34358343 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study 33640591 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-criticism induction
Number of subjects: 0
Study 33640591 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-compassion induction
Number of subjects: 0
Study 33640591 — intervention group
Group type: COMPARATOR
Intervention: Neutral control condition
Number of subjects: 0
Study 36272353 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 18µg
Number of subjects: 34
Study 36272353 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrronium 44µg
Number of subjects: 34
Study 36272353 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol 150µg
Number of subjects: 34
Study 36272353 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 34
Study 32818546 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive media information
Number of subjects: 2176
Study 32818546 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative media information
Number of subjects: 2176
Study 32818546 — intervention group
Group type: COMPARATOR
Intervention: Reference group (no media information)
Number of subjects: 2176
Study 35449062 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS anodal stimulation
Number of subjects: 23
Study 35449062 — intervention group
Group type: COMPARATOR
Intervention: tDCS cathodal stimulation
Number of subjects: 23
Study 35449062 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 23
Study 33144646 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodic stimulation for five consecutive days
Number of subjects: 31
Study 33144646 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodic stimulation for ten consecutive days
Number of subjects: 31
Study 33144646 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation for five consecutive days
Number of subjects: 31
Study 35684150 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive parenting intervention
Number of subjects: 185
Study 35684150 — intervention group
Group type: COMPARATOR
Intervention: Child safety control intervention
Number of subjects: 185
Study 34161616 — intervention group
Group type: EXPERIMENTAL
Intervention: Eliglustat
Number of subjects: 40
Study 34011736 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal crosslinking (CXL)
Number of subjects: 18
Study 34011736 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (no CXL)
Number of subjects: 18
Study 32078391 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab 2 mg/kg or 10 mg/kg every 3 weeks (up to 35 cycles/2 years)
Number of subjects: 1033
Study 32078391 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel 75 mg/m2 every 3 weeks
Number of subjects: 1033
Study 32078391 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab (second-course treatment)
Number of subjects: 1033
Study 32078391 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab (after completing treatment)
Number of subjects: 1033
Study 35419725 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture intervention at two acupoint groups for 30 min once every other day during ovulation induction until transplantation day, consisting of 3 courses.
Number of subjects: 83
Study 35419725 — intervention group
Group type: COMPARATOR
Intervention: Control group (no acupuncture intervention).
Number of subjects: 83
Study 35419725 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture intervention.
Number of subjects: 83
Study 33846971 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg CBD
Number of subjects: 100
Study 33846971 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 32221185 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer use
Number of subjects: 199
Study 33945842 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity and diet intervention; physical activity, diet, and sleep intervention
Number of subjects: 116
Study 32076105 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS intervention
Number of subjects: 38
Study 32076105 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS intervention
Number of subjects: 38
Study 35887581 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-specific spinal drill guides (3DPGs)
Number of subjects: 10
Study 35887581 — intervention group
Group type: COMPARATOR
Intervention: Computer-assisted surgery (CAS)
Number of subjects: 10
Study 32629639 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimodal home-based prehabilitation (nutritional, psychological, and exercise interventions)
Number of subjects: 128
Study 32629639 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prehabilitation)
Number of subjects: 128
Study 35384847 — intervention group
Group type: EXPERIMENTAL
Intervention: OnTrack>The Game (OTG)
Number of subjects: 16
Study 35384847 — intervention group
Group type: COMPARATOR
Intervention: Recovery Videos (RVs)
Number of subjects: 16
Study 36179725 — intervention group
Group type: EXPERIMENTAL
Intervention: High depressive symptoms group (14 participants)
Number of subjects: 24
Study 36179725 — intervention group
Group type: COMPARATOR
Intervention: Low depressive symptoms group (10 participants)
Number of subjects: 24
Study 32935561 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) - Dexcom G6
Number of subjects: 99
Study 32935561 — intervention group
Group type: COMPARATOR
Intervention: Finger Stick Glucometer (FSG) - Contour Next One
Number of subjects: 99
Study 35583161 — intervention group
Group type: EXPERIMENTAL
Intervention: Prowel® (synbiotic drug)
Number of subjects: 100
Study 35583161 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 34751654 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat-based intervention comprising cognitive-behavioral stress management (CBSM) courses and physical activity promotion for 3 months
Number of subjects: 300
Study 34751654 — intervention group
Group type: COMPARATOR
Intervention: Printed brochure on nutrition guidelines in addition to usual care for HIV treatment
Number of subjects: 300
Study 32072434 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 223
Study 32072434 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity (PA) intervention
Number of subjects: 223
Study 32072434 — intervention group
Group type: COMPARATOR
Intervention: Combined intervention
Number of subjects: 223
Study 32072434 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 223
Study 35419911 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-01
Number of subjects: 0
Study 35419911 — intervention group
Group type: COMPARATOR
Intervention: Ellansé-M®
Number of subjects: 0
Study 35419911 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-01 and Ellansé-M®
Number of subjects: 0
Study 34418719 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression (2 kg pressure applied after FNB)
Number of subjects: 34
Study 34418719 — intervention group
Group type: COMPARATOR
Intervention: No Compression (no pressure applied after FNB)
Number of subjects: 34
Study 32859145 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg)
Number of subjects: 24
Study 32859145 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 mg/kg dextrose)
Number of subjects: 24
Study 32459016 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 6% gabapentin
Number of subjects: 30